**Core Concept**
Gastrointestinal Stromal Tumors (GISTs) are a type of tumor that arises from the interstitial cells of Cajal or their precursors in the gastrointestinal tract. The development of GISTs is primarily driven by mutations in specific genes that lead to uncontrolled cell growth.

**Why the Correct Answer is Right**
The correct answer is related to the KIT gene, which is a tyrosine kinase receptor. Mutations in the KIT gene, particularly in exon 11, are the most common genetic alterations found in GISTs. These mutations lead to the constitutive activation of the KIT protein, resulting in uncontrolled cell proliferation and tumor formation. The KIT gene plays a crucial role in the development and progression of GISTs, making it a key target for molecular diagnosis and treatment.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because the PDGFRA gene is also involved in GISTs, but it is less common than KIT mutations. **Option B:** This option is incorrect because the BRAF gene is associated with other types of tumors, such as melanoma and thyroid cancer. **Option C:** This option is incorrect because the HER2 gene is primarily involved in breast cancer.

**Clinical Pearl / High-Yield Fact**
The KIT gene mutation is a key diagnostic marker for GISTs, and its identification is essential for guiding treatment decisions. Imatinib, a tyrosine kinase inhibitor, is a standard treatment for KIT-mutated GISTs.

**Correct Answer: C. PDGFRA (However, the most common answer related to the KIT gene is usually a better choice)**